Home Page
03:20:55 EDT Tue 22 Jul 2014
Enter Symbol
or Name
USA
CA



PDL BIOPHARMA INC
Symbol U : PDLI
Recent Sedar Documents

PDL BioPharma to Hold Annual Meeting of Stockholders on May 21, 2013

2013-03-06 16:05 ET - News Release

INCLINE VILLAGE, Nev., March 6, 2013 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the company will hold its annual meeting of stockholders on Tuesday, May 21, 2013, at 10:00 a.m. Pacific Time for all stockholders of record on March 28, 2013. The meeting will take place at the Hyatt Regency Hotel in Incline Village, Nevada.  

(Logo: http://photos.prnewswire.com/prnh/20110822/SF55808LOGO)

About PDL BioPharma
PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDL is focused on intellectual property asset management, investing in new income generating assets and maximizing value for its shareholders. For more information, please visit www.pdl.com.

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.

 

SOURCE PDL BioPharma, Inc.

© 2014 Canjex Publishing Ltd. All rights reserved.